Our Mission is to expedite the development of a treatment or cure for Limb Girdle Muscular Dystrophy 2I (LGMD2I). We do that by building a comprehensive view of the entire LGMD2I research landscape, supporting the most promising research projects, and coordinating and managing the scientific process.


We are not a fundraising organization and do not solicit donations.


To achieve our mission, our strategy relies on the five following actions:


  • Foster basic research on LGMD2I.
  • Support the generation of research tools, such as antibodies, animals models and gene therapy vectors.
  • Support the identification of patients.
  • Support studies to generate biomarkers and outcome measures to be used in clinical trials.
  • Accelerate translation of promising scientific discoveries into clinics by supporting its early stage development in collaboration with industry.


For more information, please contact:


Dr. Jean-Pierre Laurent

Program Officer

E-mail: jpl@lgmd2ifund.org

Phone: (425) 460-2554
Fax: (425) 460-1236